InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Wednesday, 03/18/2015 8:48:01 PM

Wednesday, March 18, 2015 8:48:01 PM

Post# of 346191
If Sunrise proves that Bavi adds 50% to the MOS of the 2nd Line NSCLC patients, I wonder if they are considering repeating the treatment once the disease starts to progress. Rinse and repeat. Buy the patients more months of life?

GLTA, Paul
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News